Invokana Cancer Risks
Early trials for Invokana demonstrated an increased risk of kidney and bladder cancer. However, the FDA still approved the medication and did not place a warning for the potential risk of Invokana cancer. Previous diabetic drugs such as Actos had massive lawsuits due to the failure to warn about the risk of bladder cancer. Now those taking this Type 2 diabetic drug could have a similar cancer risk.
Invokana was the first in a new class of drugs for Type 2 diabetics. It was supposed to help people easily manage their diabetes without insulin by lowering blood sugar by causing the kidneys to remove sugar from the body via urine. This prevents blood from reabsorbing the sugar. In March 2013, the FDA approved Invokana. However, by May 2015 they were warning that Invokana may lead to devastating side effects.
Invokana Cancer Studies
An Invokana study commissioned by the European Commission found that rat studies suggested an increased risk for renal, adrenal, and Leydig cell tumors. Researchers also pinpointed that the renal (kidney) function is paramount to the efficacy of Invokana. When a patient has impaired renal function, then their risk for Invokana cancer dramatically increases. Plus, the higher the dose of medication the more likely the patient could develop cancer. However, the evidence is not conclusive at this time. Therefore, this drug remains a huge safety concern. Many researchers are urging more studies with larger sample sizes, longer exposure duration and use of Invokana in difference ethnicities.
If you or a loved one has been harmed by Invokana, you need an attorney with experience helping people who have been harmed by pharmaceutical drugs. The attorneys at the Michael Brady Lynch Firm know what it takes to go up against drug manufacturers to get clients what they need.
If the conduct of a drug company in manufacturing and selling drugs is found to be highly reckless, punitive damages may be awarded to punish the company and deter similar conduct in the future. If you developed complications after taking Invokana, please speak to us to learn more about your rights.
At the present time, The Michael Brady Lynch Firm is concentrating on Pennsylvania. This is the location where our cases are pending against the makers of Invokana. As of June 2016, plaintiffs filed approximately 41 cases Philadelphia for those living all across the country. This will most likely mean a mass tort consolidation at the Federal level is imminent.
You deserve compensation. It can never replace what you have lost. But, it can help you recover medical expenses, lost wages and the loss of an ability to work. The consultation is completely free, and you are under zero obligation. We are available 24/7 to take your call.